From Multiomics to Mechanisms – Microbiome-Gut-Host Interactions as a Pathogenetic Driver of Parkinson's Disease Subtypes

Bidragets beskrivning

Parkinson's disease (PD) affects over 5 million people worldwide and 15.000 in Finland. The microbiota-gut-brain axis (MGBA) affects PD symptoms and pathology. Different subtypes of PD may exist with the location of first pathological changes being either in the brain (brain first) or the autonomic nervous system, specifically the gut (body first). Treatments that do not account for such differences will likely fail. We will identify subtypes of PD already in the prodromal phase (before motor symptoms appear) by analyzing genes, gut bacteria, metabolism, and inflammation to profile the MGBA in a large longitudinal cohort of elderly individuals and PD patients. We will compare MGBA pathway alterations (=biomarkers) across different subtypes and disease stages. We will confirm MGBA effects by assessing how fecal microbiota transplantation to rodent models worsens or alleviates PD pathology. This will eventually lead to new personalized treatments for PD.
Visa mer

Startår

2021

Slutår

2025

Beviljade finansiering

Filip Scheperjans Orcid -palvelun logo
500 000 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiprojekt

Övriga uppgifter

Finansieringsbeslutets nummer

342758

Vetenskapsområden

Biomedicinska vetenskaper

Forskningsområden

Systeemibiologia, bioinformatiikka

Temaområden

Nuori tutkijasukupolvi 2020

Identifierade teman

brain, neuroscience